SUMO-specific protease 1 regulates the in vitro and in vivo growth of colon cancer cells with the upregulated expression of CDK inhibitors

Cancer Letters

Volumn 309, Issue 1, 2011, Pages 78-84

  Xu, Ying ^a,b   Li, Jie ^b   Zuo, Yong ^b   Deng, Jiong ^b   Wang, Li Shun ^b   Chen, Guo Qiang ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

CDK inhibitors; Cell growth; G1 arrest; SENP1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2D; SMALL INTERFERING RNA; SUMO PROTEIN; SUMO SPECIFIC PROTEASE 1; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; COLON CANCER; CONTROLLED STUDY; FEMALE; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; ENDOPEPTIDASES; G1 PHASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; RNA, SMALL INTERFERING; UP-REGULATION;

MUS MUSCULUS;

EID: 79959839402     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.05.019     Document Type: Article

References (28)

1. Geiss-Friedlander R., Melchior F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 2007, 8:947-956.
2. Hay R.T. SUMO: a history of modification. Mol. Cell. 2005, 18:1-12.
3. Yeh E.T. SUMOylation and De-SUMOylation: wrestling with life's processes. J. Biol. Chem. 2009, 284:8223-8227.
4. Mukhopadhyay D., Dasso M. Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 2007, 32:286-295.
5. Cheng J., Kang X., Zhang S., Yeh E.T. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 2007, 131:584-595.
6. Xu Y., Zuo Y., Zhang H., Kang X., Yue F., Yi Z., Liu M., Yeh E.T., Chen G., Cheng J. Induction of SENP1 in endothelial cells contributes to hypoxia-driven VEGF expression and angiogenesis. J. Biol. Chem. 2010, 285:36682-36688.
7. Cheng J., Wang D., Wang Z., Yeh E.T. SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol. Cell Biol. 2004, 24:6021-6028.
8. Cheng J., Perkins N.D., Yeh E.T. Differential regulation of c-Jun-dependent transcription by SUMO-specific proteases. J. Biol. Chem. 2005, 280:14492-14498.
9. Cheng J., Bawa T., Lee P., Gong L., Yeh E.T. Role of desumoylation in the development of prostate cancer. Neoplasia 2006, 8:667-676.
10. Hans F., Dimitrov S. Histone H3 phosphorylation and cell division. Oncogene 2001, 20:3021-3027.
11. Xu H.Z., Huang Y., Wu Y.L., Zhao Y., Xiao W.L., Lin Q.S., Sun H.D., Dai W., Chen G.Q. Pharicin A, a novel natural ent-kaurene diterpenoid, induces mitotic arrest and mitotic catastrophe of cancer cells by interfering with BubR1 function. Cell Cycle 2010, 9:2897-2907.
12. Li S.J., Hochstrasser M. A new protease required for cell-cycle progression in yeast. Nature 1999, 398:246-251.
13. Nishida T., Tanaka H., Yasuda H. A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase. Eur. J. Biochem. 2000, 267:6423-6427.
14. Klein U.R., Haindl M., Nigg E.A., Muller S. RanBP2 and SENP3 function in a mitotic SUMO2/3 conjugation-deconjugation cycle on Borealin. Mol. Biol. Cell. 2009, 20:410-418.
15. Di Bacco A., Gill G. SUMO-specific proteases and the cell cycle. An essential role for SENP5 in cell proliferation. Cell Cycle 2006, 5:2310-2313.
16. Di Bacco A., Ouyang J., Lee H.Y., Catic A., Ploegh H., Gill G. The SUMO-specific protease SENP5 is required for cell division. Mol. Biol. Cell 2006, 26:4489-4498.
17. Zunino R., Braschi E., Xu L., McBride H.M. Translocation of SENP5 from the nucleoli to the mitochondria modulates DRP1-dependent fission during mitosis. J. Biol. Chem. 2009, 284:17783-17795.
18. Bawa-Khalfe T., Cheng J., Lin S.H., Ittmann M.M., Yeh E.T. SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms. J. Biol. Chem. 2010, 285:25859-25866.
19. Bawa-Khalfe T., Yeh E.T. SUMO losing balance: SUMO proteases disrupt SUMO homeostasis to facilitate cancer development and progression. Genes Cancer 2010, 1:748-752.
20. Bawa-Khalfe T., Cheng J., Wang Z., Yeh E.T. Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells. J. Biol. Chem. 2007, 282:37341-37349.
21. Shackelford R.E., Kaufmann W.K., Paules R.S. Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ. Health Perspect. 1999, 107(Suppl. 1):5-24.
22. Malumbres M., Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 2009, 9:153-166.
23. Burhans W.C., Heintz N.H. The cell cycle is a redox cycle: linking phase-specific targets to cell fate. Free Radical Biol. Med. 2009, 47:1282-1293.
24. Dozio E., Ruscica M., Passafaro L., Dogliotti G., Steffani L., Marthyn P., Pagani A., Demartini G., Esposti D., Fraschini F., Magni P. The natural antioxidant alpha-lipoic acid induces p27Kip1-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells. Eur. J. Pharmacol. 2010, 641:29-34.
25. Gartel A.L., Serfas M.S., Tyner A.L. P21-negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med. 1996, 213:138-149.
26. Wang X., Pan L., Feng Y., Wang Y., Han Q., Han L., Han S., Guo J., Huang B., Lu J. P300 plays a role in p16INK4a expression and cell cycle arrest. Oncogene 2008, 27:1894-1904.
27. Weber J.D., Jeffers J.R., Rehg J.E., Randle D.H., Lozano G., Roussel M.F., Sherr C.J., Zambetti G.P. P53-independent functions of the p19ARF tumor suppressor. Genes Dev. 2000, 14:2358-2365.
28. Wolf G. Cell cycle regulation in diabetic nephropathy. Kidney Int. 2000, (Suppl. 77):S59-S66.